{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:45:53Z","timestamp":1792687553232,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.npep.2008.03.002","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T16:13:48Z","timestamp":1209485628000},"page":"267-276","source":"Crossref","is-referenced-by-count":51,"title":["Neuroprotective effects of PACAP27 in mice model of Parkinson\u2019s disease involved in the modulation of KATP subunits and D2 receptors in the striatum"],"prefix":"10.1016","volume":"42","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2008.03.002_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/er.20.2.101","article-title":"Molecular biology of adenosine triphosphate-sensitive potassium channels","volume":"20","author":"Aguilar-Bryan","year":"1999","journal-title":"Endocrinol. Rev."},{"key":"10.1016\/j.npep.2008.03.002_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1749-6632.1996.tb17489.x","article-title":"Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons","volume":"805","author":"Banks","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.npep.2008.03.002_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cellsig.2006.12.006","article-title":"PACAP stimulates the sustained phosphorylation of tyrosine hydroxylase at serine 40","volume":"19","author":"Bobrovskaya","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.npep.2008.03.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1353-8020(03)00097-X","article-title":"Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson\u2019s disease","volume":"10","author":"Chen","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.npep.2008.03.002_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1471-4159.1998.71020478.x","volume":"71","author":"Corbitt","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2008.03.002_bib6","first-page":"775","article-title":"Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes","volume":"277","author":"DeBoer","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2008.03.002_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(99)02015-6","article-title":"Differential regulation of striatal dopamine D(1) and D(2) receptors in acute and chronic parkinsonian monkeys","volume":"847","author":"Decamp","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2008.03.002_bib8","first-page":"307","article-title":"Neuroprotective potential of three neuropeptides PACAP, VIP and PHI","volume":"57","author":"Dejda","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.npep.2008.03.002_bib9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/1381612043384934","article-title":"Passage of VIP\/PACAP\/secretin family across the blood-brain barrier: therapeutic effects","volume":"10","author":"Dogrukol-Ak","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2008.03.002_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(98)00956-1","article-title":"Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain","volume":"814","author":"Dunn-Meynell","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2008.03.002_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2004.05.014","article-title":"Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury","volume":"123","author":"Farkas","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2008.03.002_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson\u2019s disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2008.03.002_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/frne.1998.0168","article-title":"Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system","volume":"19","author":"Hoffman","year":"1998","journal-title":"Front Neuroendocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.npep.2008.03.002_bib14","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1291\/hypres.18.SupplementI_S169","article-title":"Pituitary adenylate cyclase-activating polypeptide stimulates the synthesis of dopamine in cultured bovine adrenal chromaffin cells","volume":"18","author":"Houchi","year":"1995","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.npep.2008.03.002_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00005537-200306000-00016","article-title":"Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig","volume":"113","author":"Kimura","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.npep.2008.03.002_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.regpep.2004.04.020","article-title":"PACAP facilitate the nerve regeneration factors in the facial nerve injury","volume":"123","author":"Kimura","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2008.03.002_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/syn.890150107","article-title":"Dopamine transporter mutants selectively enhance MPP+ transport","volume":"15","author":"Kitayama","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2008.03.002_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0167-4889(98)00071-8","article-title":"MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters","volume":"1404","author":"Kitayama","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.npep.2008.03.002_bib19","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1517\/13543784.9.10.2269","article-title":"Is there a role for potassium channel openers in neuronal ion channel disorders?","volume":"9","author":"Lawson","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.npep.2008.03.002_bib20","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/nn1570","article-title":"K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons","volume":"8","author":"Liss","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.npep.2008.03.002_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.neuro.20.1.125","article-title":"The role of vesicular transport proteins in synaptic transmission and neural degeneration","volume":"20","author":"Liu","year":"1997","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.npep.2008.03.002_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1054\/npep.1999.0768","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP-27) enhances tyrosine hydroxylase activity in the nucleus accumbens of the rat","volume":"33","author":"Moser","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2008.03.002_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0196-9781(02)00085-2","article-title":"The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells","volume":"23","author":"Onoue","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2008.03.002_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(02)02886-7","article-title":"PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106\u2013126","volume":"522","author":"Onoue","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2008.03.002_bib25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.31.6.1411","article-title":"Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat","volume":"31","author":"Reglodi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.npep.2008.03.002_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.2000.tb06958.x","article-title":"Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions","volume":"921","author":"Reglodi","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.npep.2008.03.002_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.regpep.2004.05.016","article-title":"Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats","volume":"123","author":"Reglodi","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2008.03.002_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbr.2003.09.007","article-title":"Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson\u2019s disease","volume":"151","author":"Reglodi","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2008.03.002_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1196\/annals.1317.072","article-title":"Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson\u2019s disease","volume":"1070","author":"Reglodi","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.npep.2008.03.002_bib30","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0196-9781(02)00262-0","article-title":"Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia","volume":"23","author":"Reglodi","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2008.03.002_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.npep.2006.06.001","article-title":"Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats","volume":"40","author":"Reglodi","year":"2006","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2008.03.002_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(24)39239-0","article-title":"In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium","volume":"293","author":"Staal","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2008.03.002_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1749-6632.2001.tb03642.x","article-title":"Rescue of dying neurons by (R)-deprenyl in the MPTP-mouse model of Parkinson\u2019s disease does not include restoration of neostriatal dopamine","volume":"939","author":"Steyn","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.npep.2008.03.002_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1006\/exnr.2000.7610","article-title":"Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL\/6 mice has no effect on basal neostriatal dopamine levels","volume":"168","author":"Steyn","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2008.03.002_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5","article-title":"Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons","volume":"54","author":"Takei","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2008.03.002_bib36","first-page":"249","article-title":"Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats","volume":"23","author":"Tamas","year":"2002","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.npep.2008.03.002_bib37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/neu.2006.23.686","article-title":"Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats","volume":"23","author":"Tamas","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.npep.2008.03.002_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1196\/annals.1317.083","article-title":"Protective effects of PACAP in excitotoxic striatal lesion","volume":"1070","author":"Tam\u00e1s","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.npep.2008.03.002_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(99)01209-3","article-title":"Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP","volume":"824","author":"Tanji","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2008.03.002_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-8993(03)03222-0","article-title":"The Kir6.1-protein, a pore-forming subunit of ATP-sensitive potassium channels, is prominently expressed by giant cholinergic interneurons in the striatum of the rat brain","volume":"986","author":"Thomzig","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2008.03.002_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jnr.10530","article-title":"Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells","volume":"72","author":"Vaudry","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2008.03.002_bib42","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1016\/j.febslet.2005.06.013","article-title":"PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone","volume":"579","author":"Wang","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2008.03.002_bib43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.neuropharm.2005.01.009","article-title":"Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson\u2019s disease: implications for treating Parkinson\u2019s disease?","volume":"48","author":"Wang","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2008.03.002_bib44","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1208\/aapsj080478","article-title":"Vesicular monoamine transporter 2: role as a novel target for drug development","volume":"8","author":"Zheng","year":"2006","journal-title":"Aaps J."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417908000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417908000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:22:28Z","timestamp":1738192948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417908000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0143417908000437"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2008.03.002","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}